Edward J. Damrose, MD, FACS

Publication Details

• A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.

  Morzaria S, Damrose EJ. J Voice. 2012; 26 (3): 378-80

  Although disease-specific quality-of-life (QOL) instruments are an invaluable outcome measure in spasmodic dysphonia, there is no consensus on which QOL instrument should be used.

  PubMedID: 20951552